My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


OpenAI, Anthropic, SpaceX IPOs Could End Big...
Adobe Pauses Price Hikes For 'Short-Term' AI...
Trump Says Iran 'Better Get Their Act Togethe...
GameStop Didn't Make Money With Its Bitcoin B...
Value Investors Question SpaceX's Record IPO:...
Google Sounds Alarm On Active Oracle PeopleSo...
Chinese Customers Can Now Order NVIDIA's Vera...
SpaceX's IPO Could Spark A Venture Capital Fr...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    ABBVIE INC (NYSE: ABBV)

    Overview
    current price
    $227.73
    $227.73
    change
    2.96 | 1.32%
    2.96 | 1.32%
    Yesterday's Close
    224.77
    open
    227.50
    volume
    4.09 M
    30d. avg volume.
    5.63 M
    1 day
    224.32 - 228.40
    52 weeks
    181.73 - 244.81
    p/e
    112.18
    beta
    0.3198
    market cap
    402.35 B
    dividend yield
    3.04%
    Industry
    -
    ABBV by TradingView
    News and Commentary
    AbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment AbbVie Inc. (ABBV&nbsp...
    Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on...
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stol... U.S. drug wholesaler Cencora Inc (
    Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Exper... Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.This growth w...
    AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains AbbVie Inc (ABBV ...
    Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine Johnson & Johnson (JNJ&...
    Pharmaceutical Giant Merck Challenges Inflation Reduction Act over Medicare Drug Pricing, Calls It '... Merck & Co Inc (MRK&nbs...
    Drug Maker Games the Patent System to Rake in $114 Billion The pharmaceutical giant AbbVie (
    October 28 Market Summary Global investors on Friday digested new data, policy statements, and earnings reports. In Europe, the MOEX Russia Index edged up 0.14%, the British FTSE dipped 0.37%, the German...
    October 25 Market Summary Global investors on Tuesday digested new data, policy statements, and earnings reports. In Europe, the MOEX Russia Index soared 3.23%, the British FTSE edged down 0.01%, the Germ...
    StockTwits
    StockTwits
    Most Shared
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Best Buy Stock Pops After Strong Comparable Sales, Margin Growth
    US Says China To Buy At Least $17 Billion Worth Agricultural Goods Annually After Trump-Xi Meet
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    The AI Spending Boom Just Got Bigger: Goldman Sees $800 Billion Flowing In This Year
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?